About Abacus Medicine
Abacus Medicine is a company based in Copenhagen (Denmark) founded in 2004 by John Wagner and Flemming Wagner. Abacus Medicine has raised $57.64 million across 8 funding rounds from investors including Chr. Augustinus Fabrikker. The company has 1,052 employees as of December 31, 2021. Abacus Medicine offers products and services including Parallel Imported Medicines, Clinical Trial Services, and Pharmaceutical Wholesaling. Abacus Medicine operates in a competitive market with competitors including OPEN Health, Target RWE, Secura Bio, STATinMED Research and Hylant, among others.
- Headquarter Copenhagen, Denmark
- Employees 1052 as on 31 Dec, 2021
- Founders John Wagner, Flemming Wagner
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abacus Medicine A/S
-
Annual Revenue
Not available
-
Net Profit
-$2.83 K (USD)-29as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$57.64 M (USD)
in 8 rounds
-
Latest Funding Round
$206.4 K (USD), Series B
Jul 01, 2020
- Investors
-
Employee Count
1052
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abacus Medicine
Abacus Medicine offers a comprehensive portfolio of products and services, including Parallel Imported Medicines, Clinical Trial Services, and Pharmaceutical Wholesaling.
Provides affordable prescription medicines through parallel importing for cost savings.
Offers support for clinical trials in pharmaceutical research and development.
Handles wholesale of medical devices and direct patient services across Europe.
People of Abacus Medicine
Unlock access to complete
Unlock access to complete
Software Development Team
26 people
Sales and Marketing
18 people
Finance and Accounting
12 people
Portfolio Team
12 people
Leadership Team
6 people
Human Resources and Administration
6 people
Product Management Team
6 people
Board Team
5 people
Unlock access to complete
Funding Insights of Abacus Medicine
Abacus Medicine has successfully raised a total of $57.64M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $206.4 thousand completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Abacus Medicine
Abacus Medicine has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Chr. Augustinus Fabrikker.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked |
Investor details for Abacus Medicine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abacus Medicine
Investment portfolio details for Abacus Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Abacus Medicine
Detailed financials for Abacus Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abacus Medicine Comparisons
Peer comparison for Abacus Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Abacus Medicine
Abacus Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Secura Bio, STATinMED Research and Hylant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of healthcare marketing services
|
|
| Locked | Locked | Locked |
Marketing services to the pharmaceutical industry are provided.
|
|
| Locked | Locked | Locked |
Consulting services for market access and health outcomes are provided.
|
|
| Locked | Locked | Locked |
Healthcare data analytics services provider
|
|
| Locked | Locked | Locked |
Offers business insurance, employee benefits, and risk consulting services worldwide.
|
Detailed competitors of Abacus Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abacus Medicine
Complete news archive for Abacus Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abacus Medicine
Abacus Medicine was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Abacus Medicine is headquartered in Copenhagen, Denmark.
Flemming Wagner is the current CEO of Abacus Medicine. They have also founded this company.
Abacus Medicine is a funded company, having raised a total of $57.64M across 8 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Abacus Medicine is 1,052.
Abacus Medicine was founded in 2004 in Copenhagen, Denmark, within the pharmaceutical consulting sector. Services are offered in market access strategies, health economics evaluations, and outcomes research. Additional areas include strategic business development support, quality and compliance management, cGMP adherence, clinical monitoring, and pharmaceutical sales assistance. Operations focus on health-related consulting for various clients.
Abacus Medicine's top competitors include OPEN Health, Target RWE and STATinMED Research.
Abacus Medicine offers Parallel Imported Medicines, Clinical Trial Services, and Pharmaceutical Wholesaling.
Abacus Medicine has 1 investor. Key investors include Chr. Augustinus Fabrikker.
The valuation of Abacus Medicine is $20.93M as of Jul 2020.